Glenmark Pharmaceuticals Ltd Results

Glenmark Pharmaceuticals Ltd’s revenue jumped 15.4% since last year same period to ₹3,945.08Cr in the Q3 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -36.85% fall in its revenue since last 3-months.

Glenmark Pharmaceuticals Ltd’s net profit jumped 15.88% since last year same period to ₹403.21Cr in the Q3 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -33.94% fall in its net profits since last 3-months.

Glenmark Pharmaceuticals Ltd’s net profit margin jumped 0.42% since last year same period to 10.22% in the Q3 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 4.62% jumped in its net profit margins since last 3-months.